Do we still need the TRH stimulation test?

Thyroid

Volumn 17, Issue 6, 2007, Pages 529-533

  Atmaca, Hulusi ^a   Tanriverdi, Fatih ^b   Gokce, Cumali ^b   Unluhizarci, Kursad ^b   Kelestimur, Fahrettin ^b  

^a Zonguldak Karaelmas Universitesi Tip Fakultesi   (Turkey)

^b ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; PROTIRELIN; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HORMONE RELEASE; HUMAN; HYPOPITUITARISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTIRELIN TEST; THYROTROPIN BLOOD LEVEL;

ADULT; AGED; FEMALE; HUMANS; HYPOPITUITARISM; HYPOTHYROIDISM; INJECTIONS, INTRAVENOUS; MIDDLE AGED; THYROTROPIN; THYROTROPIN-RELEASING HORMONE;

EID: 34447523582     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.0311     Document Type: Article

References (15)

1. Faglia G 1998 The clinical impact of the thyrotropin-releasing hormone test. Thyroid 8:903-908.
2. Allahabadia A, Weetman AP 2003 Dynamic thyroid stimulating hormone tests: do they still have a role? J Endocrinol Invest 26(7 suppl):31-38.
3. Kelestimur F 2003 Sheehan's syndrome. Pituitary 6:181-188.
4. Bayram F, Ünlühizarci K, Keleştimur F 1996 Erciyes Üniversitesi Tip Fakültesi'nde son 7 yilda görülen Sheehan sendromlu hastalarin retrospektif deǧerlendirilmesi. Ulusal Endokrinoloji Dergisi 6:279-291.
5. Hartoft-Nielsen ML, Lange M, Rasmussen AK, Scherer S, Zimmermann-Belsing T, Feldt-Rasmussen U 2004 Thyrotropin-releasing hormone stimulation test in patients with pituitary pathology. Horm Res 61:53-57.
6. Ross DS 2001 Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease. Endocrinol Metab Clin North Am 30:245-264.
7. Christ-Crain M, Meier C, Roth CB, Huber P, Staub JJ, Müller B 2002 Basal TSH levels compared with TRH-stimulated TSH levels to diagnose different degrees of TSH suppression: diagnostic and therapeutic impact of assay performance. Eur J Clin Invest 32:931-937.
8. Lamberts SW, de Herder WW, van der Lely AJ 1998 Pituitary insufficiency. Lancet 352:127-134.
9. Dayan CM 2001 Interpretation of thyroid function tests. Lancet 357:619-624.
10. Beck-Peccoz P, Persani L 1994 Variable biological activity of thyroid-stimulating hormone. Eur J Endocrinol 131:331-340.
11. Joshi LR, Weintraub BD 1983 Naturally occuring forms of thyrotropin with low bioactivity and altered carbohydrate content as competitive antagonists to more bioactive forms. Endocrinology 113:2145-2154.
12. Stockell Hartree A, Renwick AG 1992 Molecular structures of glycoprotein hormones and functions of their carbohydrate components. Biochem J 287:665-679.
13. Abucham J, Castro V, Maccagnan P, Vieira JG 1997 Increased thyrotropin levels and loss of nocturnal thyrotropin surge in Sheehan's syndrome. Clin Endocrinol 47:515-522.
14. Maccagnan P, Oliveira JH, Castro V, Abucham J 1999 Abnormal circadian rhythm and increased non-pulsatile secretion in Sheehan's syndrome. Clin Endocrinol 51:439-448.
15. Oliveira JH, Persani L, Beck-Peccoz P, Abucham J 2001 Investigating the paradox of hypothyroidism and increased serum thyrotropin (TSH) levels in Sheehan's syndrome: characterization of TSH carbohydrate content and bioactivity. J Clin Endocrinol Metab 86:1694-1699.